ALGS Earnings Aligos Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–18 of 18
| Q1 2026 | 2026-03-31 | -2.21 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -2.45 | 2026-03-05 | 10-K |
| Q3 2025 | 2025-09-30 | -0.44 | 2025-11-06 | 10-Q |
| Q2 2025 | 2025-06-30 | 2.90 | 2025-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -2.11 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -20.94 | 2026-03-05 | 10-K |
| Q3 2025 | 2024-09-30 | -7.84 | 2025-11-06 | 10-Q |
| Q2 2025 | 2024-06-30 | -4.77 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -5.58 | 2025-05-06 | 10-Q |
| FY 2024 | 2023-12-31 | -34.20 | 2025-03-10 | 10-K |
| Q3 2024 | 2023-09-30 | -34.59 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.97 | 2024-08-06 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.53 | 2024-05-07 | 10-Q |
| FY 2023 | 2022-12-31 | -2.25 | 2024-03-12 | 10-K |
| Q3 2023 | 2022-09-30 | -1.74 | 2023-11-02 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.30 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.84 | 2023-05-04 | 10-Q |
| Q3 2022 | 2021-09-30 | -2.31 | 2022-11-02 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.